Physician profile
Eyerusalem H Hagos
NPI 1134662497
$3,936.94
in general payments reported to CMS, 2019-2025
18 companies · $3,672 in 2025
The $3,672 reported for 2025 was more than what 98% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $120 · 2024: $145 · 2025: $3,672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,817.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,816.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $891.35 | 2025 | Tavneos, Repatha, Krystexxa |
| Teva Pharmaceuticals USA, INC. | $574.30 | 2025 | Uzedy, Austedo Xr |
| Hologic Sales and Service, LLC | $476.38 | 2025 | Aptima |
| Sage Therapeutics, LLC | $252.53 | 2025 | |
| Neurocrine Biosciences, INC. | $219.92 | 2025 | |
| Phathom Pharmaceuticals, INC. | $207.06 | 2024-2025 | Voquezna |
| Organogenesis INC. | $174.09 | 2025 | Apligraf |
| Biomerieux INC | $162.00 | 2025 | |
| Janssen Biotech, INC. | $139.89 | 2025 | Tremfya |
| Novo Nordisk INC | $125.00 | 2025 | Wegovy |
| Urovant Sciences INC | $120.00 | 2022 | |
| Alexion Pharmaceuticals, INC. | $117.83 | 2025 | |
| Kyowa Kirin, INC. | $102.82 | 2025 | |
| Axsome Therapeutics, INC. | $100.68 | 2025 | Symbravo |
| Sumitomo Pharma America, INC. | $94.50 | 2025 | Gemtesa |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $75.60 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $52.41 | 2025 | Opsumit, Uptravi |
| Neurelis, INC. | $50.58 | 2024 | Valtoco |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eyerusalem Hagos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.